Being the only presenter from this region, Dr. Lowe's invitation to speak at this Conference at this time is significant and underscores the extent of the recognition of his work in the applied sciences with special relevance to healthcare issues, and more particularly his knowledge and contributions to advance medical cannabis internationally. Dr. Lowe has done significant research and development (R&D) work on medical cannabis and is recognized as one of the pioneers of researching, developing and commercializing medical cannabis since the 1970s. Dr. Lowe has developed strategic working relationships with scientists at the University of the West Indies, Mona as well as other academic and R&D institutions.
Having recognized the social, health and economic demand and potential of medical cannabis, Dr. Lowe launched Medicanja Limited in December 2013, the first medical cannabis company aimed at undertaking cutting edge R&D on the medicinal potentials of cannabis as well as a variety of medicinal and healthcare products which can be part of the US multi-billion dollar market. When Medicanja was launched, it created worldwide media attention, being reported through the global media network in North America, the Caribbean, Europe, Asia and Australia as a major innovation with great promise for Jamaica and the world.
One of the major aspects of Dr. Lowe's presentation will be the potential use of cannabis in cancer therapy and to alleviate the symptoms associated with "Midlife Crises" such as anxiety and depression. Dr. Lowe et al recently published a comprehensive book on ganja entitled "Ganja – the Jamaican and Global Connection" which is a handbook for anyone interested in the medicinal aspects of cannabis. Highlights from the Conference will be shared with local scientists, doctors and policymakers by Dr. Lowe in an effort to support R&D and commercialization of medical cannabis in Jamaica.
EHF Group of Companies